Department of Colorectal Surgery, The Royal Marsden Hospital, Fulham Road, London, UK.
Surg Oncol. 2013 Mar;22(1):36-47. doi: 10.1016/j.suronc.2012.11.002. Epub 2012 Dec 14.
The traditional surgical management for patients presenting with synchronous colorectal liver metastases (SCLM) has been a delayed resection. However, in some centres, there has been a shift in favour of 'simultaneous' resections. The aim of this study was to use a meta-analytical model to compare the short-term and long-term outcomes in patients with synchronous colorectal liver metastases (SCLM) undergoing simultaneous resections versus delayed resections.
Comparative studies published between 1991 and 2010 were included. Evaluated endpoints were intra-operative parameters, post-operative parameters, post-operative adverse events and survival. A random-effects meta-analytical model was used and sensitivity analysis performed to account for bias in patient selection.
Twenty-four non-randomized studies were included, reporting on 3159 patients of which 1381 (43.7%) had simultaneous resections and 1778 (56.3%) had delayed resections. The bilobar distribution (P = 0.01), size of liver metastases (P < 0.001) and the proportion of major liver resections (P < 0.001) was found to be higher in the delayed resection group compared to the simultaneous resection group. There was no significant difference in operative blood loss (95% CI, -279.28, 22.53; P = 0.1) or duration of surgery (WMD -23.83, 95% CI, -85.04, 37.38; P = 0.45). Duration of hospital stay was significantly reduced in simultaneous resections by 5.6 days (95% CI: 2.4-8.9 days, P = 0.007) No significant differences in post-operative complications (36% vs 37%, P = 0.27), overall survival (HR 1.00, 95% CI 0.86-1.15, P = 0.96) or disease free survival (HR 0.85, 95% CI 0.71-1.02, P = 0.08) were found. Sensitivity analysis revealed that these findings were consistent for the duration of hospital stay, post-operative complications, overall survival and disease free survival.
This study demonstrates that the selection criteria for patients undergoing simultaneous or delayed resections differs resulting in a discrepancy in the metastatic disease severity being compared between the two groups. The comparable intra-operative parameters, post-operative complications and survival found between the two groups suggest that delayed resections may result in better outcomes. Similarly, the reduced length of hospital stay in simultaneous resections may only be as a result of the reduced disease severity in this group. Simultaneous resections can only be recommended in patients with limited hepatic disease until prospective studies comparing similar disease burdens between the two resection groups are available.
对于同时患有结直肠肝转移(SCLM)的患者,传统的手术治疗方法是延迟切除。然而,在一些中心,已经倾向于进行“同时”切除。本研究旨在使用荟萃分析模型比较同时切除与延迟切除治疗同时患有结直肠肝转移(SCLM)的患者的短期和长期结果。
纳入 1991 年至 2010 年期间发表的比较研究。评估的终点是手术参数、术后参数、术后不良事件和生存率。使用随机效应荟萃分析模型,并进行敏感性分析以考虑患者选择偏倚。
共纳入 24 项非随机研究,报道了 3159 例患者,其中 1381 例(43.7%)接受了同时切除,1778 例(56.3%)接受了延迟切除。与同时切除组相比,延迟切除组的肝转移双侧分布(P=0.01)、肝转移大小(P<0.001)和主要肝切除术比例(P<0.001)更高。手术出血量(95%CI,-279.28,22.53;P=0.1)或手术时间(WMD-23.83,95%CI,-85.04,37.38;P=0.45)无显著差异。同时切除组的住院时间显著缩短 5.6 天(95%CI:2.4-8.9 天,P=0.007)。术后并发症(36%比 37%,P=0.27)、总生存率(HR 1.00,95%CI 0.86-1.15,P=0.96)或无病生存率(HR 0.85,95%CI 0.71-1.02,P=0.08)无显著差异。敏感性分析显示,这些发现与住院时间、术后并发症、总生存率和无病生存率一致。
本研究表明,同时或延迟切除患者的选择标准不同,导致两组之间比较的转移性疾病严重程度存在差异。两组之间发现的可比手术参数、术后并发症和生存率表明,延迟切除可能会产生更好的结果。同样,同时切除组住院时间缩短可能仅仅是因为该组疾病严重程度降低。只有在有限的肝脏疾病患者中才能推荐同时切除,直到有前瞻性研究比较两组切除之间相似的疾病负担。